1DGQ
NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | 3D_13C-SEPARATED_NOESY | 1.2 MM NMR SAMPLE OF PURIFIED AND UNIFORMLY 15N/13C ISOTOPICALLY LABELED LFA-1 I-DOMAIN | 7.2 | AMBIENT | 295 | |||
2 | 3D_15N-SEPARATED_NOESY | 1.2 MM 15N UNIFORMLY LABELED SAMPLE WAS ALSO PREPARED IN THE FOLLOWING CONDITIONS THAT WERE LESS AFFECTED BY LINE BROADENING | 7.3 | AMBIENT | 295 | |||
3 | 3D 15N HSQC-NOESY-HSQC 140 MS MIXING TIME | 1.2 MM 15N UNIFORMLY LABELED SAMPLE WAS ALSO PREPARED IN THE FOLLOWING CONDITIONS THAT WERE LESS AFFECTED BY LINE BROADENING | 7.3 | AMBIENT | 295 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | DMX | 750 |
2 | Bruker | DRX | 600 |
3 | Bruker | AMX | 500 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
TORSION ANGLE DYNAMICS SIMULATED ANNEALING | MODEL-BASED APPROACH USED TO ASSIGN NOESY SPECTRA USING EXISTING X-RAY STRUCTURES AS A MODEL. THE STRUCTURES ARE BASED ON A TOTAL OF 5656 RESTRAINTS, 2289 ARE UNIQUE NOE-DERIVED DISTANCE CONSTRAINTS, 3082 AMBIGOUS NOE-DERIVED RESTRAINTS, AND 285 DIHEDRAL ANGLE RESTRAINTS. | SANE |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | STRUCTURES WITH ACCEPTABLE COVALENT GEOMETRY, STRUCTURES WITH FAVORABLE NON- BOND ENERGY, STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS, STRUCTURES WITH THE LOWEST ENERGY |
Conformers Calculated Total Number | 100 |
Conformers Submitted Total Number | 22 |
Additional NMR Experimental Information | |
---|---|
Details | NOESY MIXING TIMES OF 60 AND 100 MS FOR THE 3D 1H-15N AND 3D 1H-13C NOESY-HSQC SPECTRA. NOESY MIXING TIME OF 140 MS FOR THE 15N HSQC-NOESY-HSQC SPECTRA. |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | data analysis | SANE | 1.0 | DUGGAN |
2 | structure solution | DYANA | 1.5 | GUENTERT |
3 | structure solution | Amber | 5.1 | CASE |
4 | refinement | Amber | 5.1 | CASE |